Preclinical investigations validate anticancer effects of alkyl-phospholipid perifosine against breast cancer cells
Background: Breast cancer is the most diagnosed cancer among women worldwide and a leading cause of cancer-related mortality. It arises from the uncontrolled growth of cells in the breast tissue, most often in the ducts or lobules. Major risk factors include genetic predisposition, hormonal influences, increasing age,...